Search research articles
Contact Us
Filters
Showing results (21-30 of 178) with videos related to
Page
of 18
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
October 23, 2017
First-in-man phase I study assessing the safety and pharmacokinetics of a 1-hour intravenous infusion of the doxorubicin prodrug DTS-201 every 3 weeks in patients with advanced or metastatic solid tumours
Patrick Schöffski, Jean-Pierre Delord, Etienne Brain, et al.
Bulletin Du Cancer
|
April 6, 2013
[The management of the metastatic disease by the surgeons]
Eliane Mery, Muriel Golzio, Benoît Thibault, et al.
Therapie
|
July 27, 2013
Drugs and cancer: an analysis of the French Pharmacovigilance Database
Geneviève Durrieu, Benjamin Mazau, Jérémi Jégu, et al.
Skin Appendage Disorders
|
February 25, 2017
Development of Photoonycholysis with Vandetanib Therapy
Miruna Negulescu, Slimane Zerdoud, Serge Boulinguez, et al.
British Journal of Cancer
|
July 3, 2026
The concept of functional cure in advanced/metastatic melanoma treated with combined nivolumab and ipilimumab or nivolumab alone
Ana Cavillon, Isabelle Borget, Caroline Robert, et al.
British Journal of Cancer
|
September 12, 2025
Acceptance of external control arms by HTA agencies: a review of oncology submissions in France, England, Germany and Norway from 2021 to 2023
Matthias Monnereau, Jean-Pierre Delord, Stefan Michiels, et al.
Bulletin Du Cancer
|
October 17, 2017
[Observational study of outpatient unit duration of stay depending on the route of administration (intravenous vs subcutaneous) for a targeted therapy]
Frédéric Despiau, Yann Zagala, Jean-Pierre Delord, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2005
Serum cystatin C is a better marker of topotecan clearance than serum creatinine
Antje Hoppe, Sophie Séronie-Vivien, Fabienne Thomas, et al.
BMC Cancer
|
June 4, 2020
Improving communication between the general practitioner and the oncologist: a key role in coordinating care for patients suffering from cancer
Vladimir Druel, Laetitia Gimenez, Kim Paricaud, et al.
Melanoma Research
|
August 28, 2015
Acute skin reaction suggestive of pembrolizumab-induced radiosensitization
Vincent Sibaud, Isabelle David, Laurence Lamant, et al.
Page
of 18
Search research articles
Search
Showing results (21-30 of 178) with videos related to
Sort By:
Page
of 18
European Journal of Cancer (Oxford, England : 1990)
|
October 23, 2017
First-in-man phase I study assessing the safety and pharmacokinetics of a 1-hour intravenous infusion of the doxorubicin prodrug DTS-201 every 3 weeks in patients with advanced or metastatic solid tumours
Patrick Schöffski, Jean-Pierre Delord, Etienne Brain, et al.
Bulletin Du Cancer
|
April 6, 2013
[The management of the metastatic disease by the surgeons]
Eliane Mery, Muriel Golzio, Benoît Thibault, et al.
Therapie
|
July 27, 2013
Drugs and cancer: an analysis of the French Pharmacovigilance Database
Geneviève Durrieu, Benjamin Mazau, Jérémi Jégu, et al.
Skin Appendage Disorders
|
February 25, 2017
Development of Photoonycholysis with Vandetanib Therapy
Miruna Negulescu, Slimane Zerdoud, Serge Boulinguez, et al.
British Journal of Cancer
|
July 3, 2026
The concept of functional cure in advanced/metastatic melanoma treated with combined nivolumab and ipilimumab or nivolumab alone
Ana Cavillon, Isabelle Borget, Caroline Robert, et al.
British Journal of Cancer
|
September 12, 2025
Acceptance of external control arms by HTA agencies: a review of oncology submissions in France, England, Germany and Norway from 2021 to 2023
Matthias Monnereau, Jean-Pierre Delord, Stefan Michiels, et al.
Bulletin Du Cancer
|
October 17, 2017
[Observational study of outpatient unit duration of stay depending on the route of administration (intravenous vs subcutaneous) for a targeted therapy]
Frédéric Despiau, Yann Zagala, Jean-Pierre Delord, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2005
Serum cystatin C is a better marker of topotecan clearance than serum creatinine
Antje Hoppe, Sophie Séronie-Vivien, Fabienne Thomas, et al.
BMC Cancer
|
June 4, 2020
Improving communication between the general practitioner and the oncologist: a key role in coordinating care for patients suffering from cancer
Vladimir Druel, Laetitia Gimenez, Kim Paricaud, et al.
Melanoma Research
|
August 28, 2015
Acute skin reaction suggestive of pembrolizumab-induced radiosensitization
Vincent Sibaud, Isabelle David, Laurence Lamant, et al.
Page
of 18